. Author manuscript; available in PMC: 2014 Apr 22.

Published in final edited form as: J Stem Cell Res Ther. 2012 Apr 20;Suppl 10:003. doi: 10.4172/2157-7633.S10-003

Table 2.

Graft cell differentiation

Group	Percent of graft cells that co-labeled for these markers mean%±SD)
Group	Nestin	MAP2	GFAP	KI67
Injection	74% (±38)	19% (±40)	0%	18% (±17)
Injection+oral	56% (±43)	12% (±20)	0%	18% (±11)
Oral	87%	0%	0%	23%
Control	48% (±50)	0%	0%	9% (±8)